All News Aeterna Zentaris Inc.

Equities

AEZS

CA0079756007

End-of-day quote Toronto S.E. Other stock markets 23:00:00 06/05/2024 BST			5-day change	1st Jan Change
11.49 ^CAD	+7.38%		+10.48%	+11.77%

04-03	North American Morning Briefing : Powell Awaited -2-	DJ
03-28	Ceapro Brief: Parties anticipate completing Transaction in Q2 2024, subject to obtaining all required approvals and satisfying all required conditions	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aeterna Zentaris Announces Effective Date of Share Consolidation	05-01	AQ
North American Morning Briefing : Powell Awaited -2-	04-03	DJ
Ceapro Brief: Parties anticipate completing Transaction in Q2 2024, subject to obtaining all required approvals and satisfying all required conditions	03-28	MT
Ceapro Brief: Says Received Final Court Approval for Merger with Aeterna Zentaris	03-28	MT
Aeterna Zentaris Reports Q4 Net Loss of US$5.6 Million, Provides DETECT Trial Update	03-27	MT
Aeterna Zentaris Brief: Announcing Completion of Enrollment in Ongoing Pivotal DETECT-Trial for Diagnosis of Childhood-Onset Growth Hormone Deficiency	03-27	MT
Aeterna Zentaris Brief: Reporting Q4 Net Loss of US$5.6 million, or $1.16 loss per common share	03-27	MT
Aeterna Zentaris Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency	03-27	AQ
Aeterna Zentaris : Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency - Form 6-K	03-27	PU
Aeterna Zentaris : Consolidated Financial Statements As of December 31, 2023 and 2022 and for the years ended December 31, 2023, 2022 and 2021 - Form 6-K	03-27	PU
North American Morning Briefing : Stocks Edge -2-	03-27	DJ
North American Morning Briefing : Markets on Hold -2-	03-20	DJ
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings	03-12	AQ
Ceapro Brief: Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR Arrangement Agreement to Approve Merger of Equals to Create a Diversified Biopharmaceutical Co	02-26	MT
Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro	02-15	AQ
Traders Search for Fresh Cues After Fed-Driven Rally as US Equity Futures Waver Pre-Bell	12-18	MT
Top Premarket Gainers	12-18	MT
AEZS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aeterna Zentaris Inc. Is Fair to Shareholders	12-14	BU
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create Diversified Biopharmaceutical Co	12-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Aeterna Zentaris Inc.

Equities

AEZS

CA0079756007

All News

Filters